What was previously expected to be a three-way battle in the novel HIF-PHI renal anemia drug class now has one man down. Akebia Therapeutics has posted a surprise trial flop, which one analyst said could hand the rival FibroGen-AstraZeneca team an early monopoly of the market. On Thursday, Akebia said its Otsuka-partnered vadadustat was linked to… Read More »
By Michael Le Page , Clare Wilson , Jessica Hamzelou , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool A medical worker takes a swab to test for the coronavirus at a drive-in testing facilityADRIAN DENNIS/AFP via Getty Images Latest coronavirus news as of 5 pm on 3 September New funding announced for trials of… Read More »
Okay, it might not be the sexiest of topics, but fungal nail infections are very common, affecting 48% of people up to the age of 70. The best fungal nail treatments will work to return discoloured nails to their healthy-looking best. Fungal nail infections usually affect your toenails but can sometimes occur on fingers. They… Read More »
AstraZeneca begins final trials of Oxford University coronavirus vaccine enrolling 50,000 people worldwide and 30,000 in the US as company signs £15million manufacturing deal Thousands volunteers already being injected with jab in UK, Brazil, South Africa Preliminary data from phase 3 trials expected ‘soon’, said lead jab researcher Developers say they hope to deliver the… Read More »